Chemotherapy-induced inflammatory seborrheic keratoses in a man with acute myeloid leukemia: a variant of Leser-Trélat sign?
Lilly, E.; Granter, S.R.; Haynes, H.A.; Ibrahimi, O.A.
Cutis 90(5): 235-236
2012
ISSN/ISBN: 0011-4162 PMID: 23270192 Document Number: 657748
Leser-Trélat sign is a controversial paraneoplastic phenomenon characterized by an eruption of seborrheic keratoses (SKs). We report a rare case of eruptive inflammatory SKs in a man undergoing induction chemotherapy for acute myeloid leukemia (AML). We also review the literature on Leser-Trélat sign.
Document emailed within 1 workday
Related Documents
Patton, T.; Zirwas, M.; Nieland-Fisher, N.; Jukic, D. 2004: Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat Journal of Drugs in Dermatology: Jdd 3(5): 565-566Turan, E.; Yesilova, Y.; Yurt, N.; Koçarslan, S. 2013: Leser-Trélat sign: does it really exist? Acta Dermatovenerologica Croatica: Adc 21(2): 123-127
Schwartz, R.A.; Helmold, M.E.; Janniger, C.K.; Gascon, P. 1991: Sign of Leser-Trélat with a metastatic mucinous adenocarcinoma Cutis 47(4): 258-260
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Burgaleta, C.; de Miguel, D.; López Rubio, M.; Krsnik, I.; Garcia Suárez, J. 2001: Myeloid natural killer cell leukemia resembling a variant of acute promyelocytic leukemia Haematologica 86(7): 765-766
Heymann, W.R. 2000: Diltiazem-induced drug eruption sparing seborrheic keratoses Cutis 66(2): 129-130
Rubisz-Brzezińska, J.; Zebracka, T.; Musiałowicz, D. 1983: Coexistence of 2 paraneoplastic syndromes - acrokeratosis bazex and Leser-Trèlat syndrome - in a case of squamous-cell laryngeal cancer Przeglad Dermatologiczny 70(2): 205-208
Cui, W.; Qing, S.; Xu, Y.; Hao, Y.; Xue, Y.; He, G. 2002: Negative stain for myeloid peroxidase and Sudan black B in acute promyelocytic leukemia (APL) cells: report of two patients with APL variant Haematologica 87(5): Ecr16
Rachmilewitz, B.; Rachmilewitz, M. 1971: Chemotherapy-induced changes in serum vitamin B 12 binding proteins in myeloid leukemia Israel Journal of Medical Sciences 7(10): 1140-1145
Garshick, M.; DeFilippis, E.M.; Harp, J.; Gaan, J. 2014: Eccrine poromatosis in a patient with acute myeloid leukemia following chemotherapy Dermatology Online Journal 20(11)
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Machover, D.; Schwarzenberg, L.; D'Hubert, E.; Lemaigre, G.; Caillou, B.; Tourani, J.M.; Michalski, B.; Goldschmidt, E.; Gaget, H.; De Vassal, F.; Misset, J.L.; Dorval, T.; Ribaud, P.; Jasmin, C.; Hayat, M.; Rappaport, H.; Mathé, G. 1982: Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study La Nouvelle Presse Medicale 11(52): 3835-3839
Koistinen, P.; Ruuska, S.; Saily, M.; Kakko, S.; Siitonen, P.; Siitonen, T.; Savolainen, M.J.; Kinnula, V.L.; Savolainen, E-Riitta. 2006: An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia Haematologica 91(6): 829-832
Tartas, N.; Grassi, D. 1991: Controversies in the treatment of acute myeloid leukemia of the adult. Chemotherapy vs bone marrow transplantation Medicina 51(4): 361-364
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Kettler, A.H.; Goldberg, L.H. 1986: Seborrheic keratoses American Family Physician 34(2): 147-152
Mustjoki, S.; Sidenius, N.; Sier, C.F.; Blasi, F.; Elonen, E.; Alitalo, R.; Vaheri, A. 2000: Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy Cancer Research 60(24): 7126-7132
Ducastelle, S.; Adès, L.; Gardin, C.; Dombret, Hé.; Prébet, T.; Deconinck, E.; Rio, B.; Thomas, X.; Debotton, S.; Guerci, Aès.; Gratecos, N.; Stamatoullas, A.; Fegueux, N.; Dreyfus, Fçois.; Fenaux, P.; Wattel, E. 2006: Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Haematologica 91(3): 373-376
Büchner, T.; Hiddemann, W.; Löffler, G.; Gassmann, W.; Maschmeyer, G.; Heit, W.; Hossfeld, D.; Weh, H.; Ludwig, W.D.; Thiel, E. 1991: Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group Seminars in Hematology 28(3 Suppl 4: 76-79